State Street’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

State Street’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,062	Closed	-$15.3K	–	4830
2022 Q4	$15.3K	Buy	1,062 +110	+12%	+$2.12K	﹤0.01%	4768
2022 Q3	$23K	Buy	952 +52	+6%	+$1.34K	﹤0.01%	4812
2022 Q2	$18K	Sell	900 -7	-0.8%	-$155	﹤0.01%	4886
2022 Q1	$32K	Buy	907 +130	+17%	+$4.83K	﹤0.01%	4858
2021 Q4	$35K	Sell	777 -1,639	-68%	-$98.3K	﹤0.01%	4747
2021 Q3	$172K	Buy	2,416 +1,607	+199%	+$183K	﹤0.01%	4410
2021 Q2	$107K	Hold	809	–	–	﹤0.01%	4352
2021 Q1	$108K	Buy	809 +99	+14%	+$12.5K	﹤0.01%	3894
2020 Q4	$52K	Buy	+710	New	+$52.1K	﹤0.01%	3845

Other funds holding ASLN

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return

State Street's ASLN Position: Q1 2023 in Review

State Street sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2023, closing a stake of 1,062 shares — an estimated $15.3K sold.

State Street first reported a position in ASLN in Q4 2020 and held it in 9 quarters. The position peaked at $172K in Q3 2021. 16 funds tracked by Wall St. Rank hold ASLN as of Q1 2023.

State Street reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2023 after selling out during the quarter.
State Street sold 1,062 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2023, an estimated $15.3K.
State Street first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2020 and held it in 9 quarters.
State Street's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $172K in Q3 2021.
16 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.